Clinical Trial Update: A Phase II Neoadjuvant Study of Apalutamide, Abiraterone Acetate, Prednisone, Degarelix and Indomethacin in Men With Localized Prostate Cancer Pre-prostatectomy [Phase 2]

View source ↗

Summary

Phase II neoadjuvant study in localized prostate cancer investigating apalutamide, abiraterone acetate, prednisone, degarelix, and indomethacin prior to prostat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Localized Prostate Cancer
• Prostate Cancer

Drugs mentioned

• Abiraterone acetate (Abiraterone acetate)
• Apalutamide (apalutamide)
• INDOMETHACIN (INDOMETHACIN)
• PREDNISONE (Prednisone)
• degarelix (degarelix)

Snippet

Sponsor: University of Washington | Conditions: Stage III Prostate Adenocarcinoma AJCC v7, Stage III Prostate Cancer AJCC v7 | Phase 2 | Status: COMPLETED | Results posted: 2020-01-18